Ipca Laboratories fell 1.73% to Rs 746 at 12:12 IST on BSE, after a bulk deal of 6.34 lakh shares was executed on the scrip at Rs 748.95 per share at 11:09 IST on BSE today, 10 December 2015.
Meanwhile, the S&P BSE Sensex was up 63.43 points or 0.25% at 25,099.48
On BSE, so far 6.51 lakh shares were traded in the counter as against average daily volume of 23,540 shares in the past one quarter.
The stock hit a high of Rs 766.95 and a low of Rs 743.50 so far during the day. The stock had hit a record high of Rs 906.90 on 28 February 2014. The stock had hit a 52-week low of Rs 591.25 on 9 February 2015.
The stock had outperformed the market over the past one month till 9 December 2015, rising 5.34% compared with 4.16% fall in the Sensex. The stock had also outperformed the market in past one quarter, rising 2.65% as against Sensex's 2.66% fall.
The mid-cap company has equity capital of Rs 25.24 crore. Face value per share is Rs 2.
More From This Section
Ipca Laboratories' net profit fell 80.9% to Rs 11.69 crore on 4.7% decline in net sales to Rs 738.58 crore in Q2 September 2015 over Q2 September 2014.
Ipca Laboratories is vertically integrated and produces finished dosage forms and active pharmaceuticals ingredients.
Powered by Capital Market - Live News